Información de Forian Inc, dividendo de Forian Inc, actividades de los accionistas y más

Más Datos de Forian Inc Compañía

Forian Inc. is a technology solutions company. The Company provides a suite of data management capabilities and data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer and provider segments. Its operations consist of providing analytic and information services to the healthcare and related industries, which are all subscription and services-based solutions. Its offerings include commercial, Real World Evidence (RWE) and market access solutions and data-driven insights to optimize the operational, clinical and financial performance of its customers. The Company provides its information solutions both as an enabling technology to consultants and service providers serving the healthcare and life sciences industries, as well as to end users in the healthcare and life sciences industries. It also offers machine learning applications for the financial services community.

Información de Forian Inc



Símbolo de cotizaciónFORA

Nombre de la empresaForian Inc

Fecha de salida a bolsaMar 03, 2021

Director ejecutivoMr. Max Wygod

Número de empleados1

Tipo de seguridadOrdinary Share

Fin del año fiscalMar 03

Dirección41 University Drive

CiudadNEWTOWN

Bolsa de valoresThe Toronto Stock Exchange

PaísUnited States of America

Código postal18940

Teléfono12677578707

Sitio Webhttps://forian.com/

Símbolo de cotizaciónFORA

Fecha de salida a bolsaMar 03, 2021

Director ejecutivoMr. Max Wygod

Ejecutivos de Forian Inc



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Shahir Kassam-Adams

Independent Director

174.93K

--

Dr. Mark J. Adler, M.D.

Independent Director

36.33K

+3.56%

Ms. Jennifer Hajj

Independent Director

10.00K

+14.29%

Ms. Alyssa F. Varadhan

Independent Director

5.00K

+33.33%

Mr. Max Wygod

Executive Chairman of the Board, President, Chief Executive Officer

--

Mr. Michael T. (Mike) Vesey

Chief Financial Officer

--

Mr. Adam Dublin

Chief Strategy Officer, Director

--

Mr. Ian G. Banwell

Independent Director

--

Dr. Kristiina S. Vuori, M.D., Ph.D.

Independent Director

--

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Shahir Kassam-Adams

Independent Director

174.93K

--

Dr. Mark J. Adler, M.D.

Independent Director

36.33K

+3.56%

Ms. Jennifer Hajj

Independent Director

10.00K

+14.29%

Ms. Alyssa F. Varadhan

Independent Director

5.00K

+33.33%

Mr. Max Wygod

Executive Chairman of the Board, President, Chief Executive Officer

--

Mr. Michael T. (Mike) Vesey

Chief Financial Officer

--

Desglose de ingresos

Divisa: USDActualizado: dom., 6 de abr

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

Por negocioUSD

Nombre

Ganancia

Proporción

Healthcare Information

16.42M

58.62%

Software Subscriptions

9.77M

34.88%

Services

1.55M

5.52%

Other

274.26K

0.98%

Sin datos

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Healthcare Information

16.42M

58.62%

Software Subscriptions

9.77M

34.88%

Services

1.55M

5.52%

Other

274.26K

0.98%

Estadísticas de accionistas

Actualizado: dom., 4 de may

Accionistas

Tipos de accionistas

Accionistas

Proporción

Vuolo (Anthony)

12.91%

Wygod (Max C)

12.40%

Dublin (Adam H)

8.35%

The Adam H. Dublin 2019 Family Trust.

5.89%

Oracle Investment Management, Inc.

4.39%

Otro

56.06%

Accionistas

Proporción

Vuolo (Anthony)

12.91%

Wygod (Max C)

12.40%

Dublin (Adam H)

8.35%

The Adam H. Dublin 2019 Family Trust.

5.89%

Oracle Investment Management, Inc.

4.39%

Otro

56.06%

Tipos de accionistas

Accionistas

Proporción

Individual Investor

44.39%

Corporation

5.89%

Investment Advisor/Hedge Fund

5.29%

Hedge Fund

3.69%

Investment Advisor

3.59%

Family Office

0.28%

Research Firm

0.16%

Otro

36.72%

Participación institucional



Actualizado: mié., 1 de oct

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q3

53

3.96M

12.73%

-855.62K

2025Q2

71

21.65M

69.40%

+1.49M

2025Q1

76

23.31M

74.88%

+2.93M

2024Q4

76

20.36M

65.61%

+917.97K

2024Q3

74

19.39M

62.41%

-972.90K

2024Q2

84

20.11M

64.71%

+282.10K

2024Q1

116

19.57M

61.30%

-681.11K

2023Q4

115

19.23M

60.20%

-763.63K

2023Q3

116

19.22M

59.03%

-685.87K

2023Q2

117

19.20M

58.98%

-791.05K

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

Vuolo (Anthony)

4.02M

12.91%

--

Apr 25, 2025

Wygod (Max C)

4.36M

14.01%

+585.19K

+15.50%

Aug 25, 2025

Dublin (Adam H)

2.61M

8.35%

+200.00K

+8.31%

Jul 15, 2025

The Adam H. Dublin 2019 Family Trust.

1.83M

5.89%

--

Apr 25, 2025

Oracle Investment Management, Inc.

1.37M

4.39%

--

Jun 30, 2025

Staley Capital Advisers, Inc.

1.10M

3.53%

--

Jun 30, 2025

Coleman (Thomas Jason)

908.48K

2.92%

--

Dec 31, 2024

Bushnell (Emily)

901.22K

2.9%

+500.83K

+125.09%

Aug 25, 2025

The Vanguard Group, Inc.

775.14K

2.49%

--

Jun 30, 2025

Spaniel (Edward Francis JR)

688.97K

2.21%

-116.25K

-14.44%

Apr 25, 2025

ETFs relacionados



Actualizado: hace 9 horas

Nombre

Proporción

iShares Micro-Cap ETF

0.01%

Dimensional US Core Equity 1 ETF

0%

DFA Dimensional US Sustainability Core 1 ETF

0%

iShares Micro-Cap ETF

Proporción0.01%

Dimensional US Core Equity 1 ETF

Proporción0%

DFA Dimensional US Sustainability Core 1 ETF

Proporción0%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos